Clinical Trial Update: The Pharmacokinetic Variability of Sunitinib in Patients With Metastatic Renal Cancer

View source ↗

Summary

A completed clinical trial update assessing the pharmacokinetic variability of sunitinib in patients with metastatic renal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Kidney Neoplasms | Status: COMPLETED